HMG-COA reductase inhibitors
AssigneeRorer Pharmaceutical Corporation
InventorsJohn R. Regan, Kent W. Neuenschwander
Life of this patent
Estimating the term…
Abstract
Disclosed are novel 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors useful as antihypercholesterolemic agents represented by the formula ##STR1## and the corresponding ring-opened hydroxy acids derived therefrom and pharmaceutically acceptable salts thereof. Pharmaceutical compositions containing said compounds and method of inhibiting the biosynthesis of cholesterol therewith are also disclosed.
Claims29
A compound of the formula ##STR10## wherein Y is:
- --CHR--,
- --CHRCHR--,
- --CHRCHRCHR--, or
- --RC.dbd.CR--;
- X, X.sub.1 and X.sub.2 are independently:
- R,
- NO.sub.2,
- NH(CO)R,
- N(R).sub.2,
- S(O).sub.m R,
- F,
- Cl, or
- Br;
- R.sub.1 is:
- OR;
- R.sub.2 is:
- R;
- R.sub.3 and R.sub.4 are independently:
- H or lower alkyl;
- R is:
- H or lower alkyl;
- n is:
- - 2;
- and
- m is:
- 0-2i
T rans-(E)-6-[2-[2-(4-fluoro-3,5-dimethylphenyl)-4-hydroxy-6,6-dimethylcycloh ex-1-en-1-yl]ethenyl-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluorophenyl)-4-hydroxy-4,6,6-trimethylcy clohex-1-en-1-yl]ethenyl]-4-hydroxy--3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluoro-3-methylphenyl)-4-methoxy-6,6-dimethylcy clohex-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluoro-3-methylphenyl)-4-methoxy-4,6,6-trimeth ylcyclohex-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluoro-3-methylphenyl)-4-butoxy-4,6,6-trimethylcycl ohex-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-nitrophenyl)-4-hydroxy-5,5-dimethylcyclopent -1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-nitro-3-methylphenyl)-4-methoxy-5,5-dime thylcyclopent-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-on e.
Trans-(E)-6-[2-[2-(4-dimethylaminophenyl)-4-hydroxy-4,6,6-trimethylcyclohe x-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-ethylthio-3-fluorophenyl)-4-propoxy-6,6- dimethylcyclohex-2-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2 -one.
T rans-(E)-6-[2-[2-(4-butylsulfonyl-3-methylphenyl)-4-hydroxy-7,7-dimethylcyc lopent-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(3-acetamidophenyl)-4-methoxy-4,7,7-triethylcycl ohept-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluoro-3-propionamidophenyl)-4-hydroxy-6,6-d imethylcyclohex-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2- one.
Trans-(E)-6-[2-[2-(4-chloro-3-ethylphenyl)-4-(1,1-dimethylethoxy)-6,6-dimet hylcyclohex-1-en-1-yl]ethenyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-6-[2-[2-(4-fluorophenyl)-4-hydroxy-6,6-dimethylcyclohex-1-en-1-yl ]ethyl]-4-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-6-[2-[2-(5-dimethylamino-4-fluoro-3-methyl phenyl)-4-ethoxy-4,6,6-trimethylcyclohex-1-en-1-yl]ethyl]-4-hydroxy-3,4,5,6 -tetrahydro-2H-pyran-2-one.
Trans-6-[2-[2-(4-fluoro -3-methylphenyl)-4-hexyloxy-6-ethyl-6-phenylcyclohex-1-en-1-yl]ethyl]4-hydr oxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(5-chloro-4-acet amido-3-methylphenyl)-4-hydroxy-6,6-dimethylcyclohex-1-en-1-yl]ethenyl]-4-h ydroxy-3,4,5,6-tetrahydro-2H-pyran-2-one.
Trans-6-[2-[2-(4-dipropylamino-3-prop ylphenyl)-4-propoxy-4,6,6-trimethylcyclohex-1-en-1-yl]ethyl]-4-hydroxy-3,4, 5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluor ophenyl)-4-methoxy-4,6,6-trimethylcyclohex-1-en-1-yl]ethenyl]-4-hydroxy-3,4 ,5,6-tetrahydro-2H-pyran-2-one.
Trans-(E)-6-[2-[2-(4-fluoro -3-methylphenyl)-4-hydroxy-6,6-dimethylcyclohex-1-en-1-yl]ethenyl]-4-hydrox y-3,4,5,6-tetrahydro-2H-pyran-2-one.
Dependencies are inferred from the claim text.